Form 4 for AURA Aura Biosciences, Inc.
Accepted 2023-01-23 00:00:00 ET · period of report 2023-01-19 · accession 0000899243-23-002436 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-23 | 2023-01-19 | AURA | De Rosch Mark | COO | A - Grant | $0.00 | +42.2K | 58.6K | +258% | $0 |
| D | 2023-01-23 | 2023-01-19 | AURA | De Rosch Mark | COO | A - Grant | — | +65.0K | 65.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-19 | A | A | 42,250 | $0.00 | 58,635 | D | — | — | (F1) These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-01-19 | A | A | 65,000 | — | 65,000 | D | $10.18 · — to 2033-01-18 | 65,000 Common Stock | (F2) The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of January 19, 2023 with the remainder vesting thereafter pro-rata in 36 monthly installments. |